Confirmation of 30mg efti as optimal biological dose relevant for Immutep’s oncology pipeline and potential future Biological License ...

An announcement from Immutep Ltd ( ($AU:IMM) ) is now available. Immutep Limited has successfully completed the FDA’s Project Optimus ...

Johns Hopkins scientists discovered a way to convert “immune-cold” tumors into “immune-hot” ones by activating key immune ...

Global Phase III trial has enrolled and randomised over 170 patients, reaching an important milestone as this is above the amount needed to ...

Immutep Ltd ( ($AU:IMM) ) just unveiled an announcement. Immutep Limited has announced a significant milestone in its TACTI-004 (KEYNOTE-F91) ...

AI Technology Group Inc. (OTCID: AIPG) (the “Company”) announced that it has filed an amended Form 10 with the Securities and ...

Advanced colon cancer is the leading cause of cancer-related death in young American men and the second highest worldwide. In ...

Australian shares are set to experience a modest rise as trading resumes in New South Wales and Queensland, with ASX 200 futures indicating a slight uptick. In this context, penny stocks remain an ...

Groundbreaking new tests reveal patterns in our immune systems that can signal underlying disease and tell us how well we ...

You will likely not get mono twice, as once you have the virus that causes mono, it will usually remain inactive in your body ...

Researchers identified immune cells that attacked the neuronal protein C9orf72 in individuals with ALS, spurring new ...

Shattuck Labs, Inc. ( NASDAQ: STTK) The United European Gastroenterology (UEG) Congress UEG Week 2025 October 8, 2025 10:00 AM EDT ...